The health care industry provides the clearest example of how AI should be governed. Not because the industry has solved the problem, but because it has no room to ignore it.
AI is already embedded across clinical documentation, diagnostics, scheduling, revenue cycle management and patient communications. It touches decisions that carry real consequences. When systems fail or outputs are wrong, the impact is immediate. That reality forces discipline in ways many other industries have not yet experienced.
In health care, AI governance is not a theoretical discussion or future-state exercise as it is with other industries and organizations. It is an operational requirement.
One of the earliest lessons learned in health care is that AI governance cannot live solely in policy documents.
AI tools were quickly adopted to reduce documentation burden, improve workflow efficiency, and manage growing volumes of data. In practice, this meant AI was directly introduced into the everyday systems that clinicians already use. Adoption did not wait for governance frameworks to mature.
But that experience exposed a gap. While traditional governance models assumed technology deployment could be reviewed, approved, and monitored at a measured pace, AI did not behave that way. Use expanded faster than oversight, and governance had to move from a compliance exercise to an operational function.
The lesson for other industries is clear: AI governance needs to exist where work actually happens. If governance is disconnected from daily operations, it will always lag behind reality.
Visibility mattered more than intent
Health care organizations also learned that AI risk often comes from a lack of visibility, not bad intent. In many cases, AI capabilities were embedded into larger platforms rather than deployed as standalone tools, but that made it harder for leadership to track where AI was active, how it influenced outputs, and who was relying on it. When visibility is limited, accountability becomes unclear.
This lack of clarity contributed directly to issues around consent and disclosure. If an organization cannot clearly map its AI usage, it cannot communicate accurately with patients or regulators.
The lesson is not that embedding AI is inherently problematic. It is that embedded AI requires stronger internal awareness. Other industries deploying AI into existing systems should expect the same challenge and plan accordingly.
Human accountability remained non-negotiable
Another lesson the health care industry learned quickly is that AI output cannot replace human responsibility. AI-generated documentation, summaries, or recommendations may be efficient, but they still require human review.
In health care, the consequences of errors forced organizations to reinforce this boundary early. AI could assist, but final responsibility stayed with clinicians and leadership.
This acknowledgement reinforced an important governance principle: AI can draft and suggest, but it cannot be the final authority. Accountability must always be traceable to a human decision-maker.
Industries outside health care often learn this lesson later, after errors scale. The health care industry’s experience shows the value of drawing that line early.
Transparency must be addressed at the system level
Transparency around AI is important both at the organizational and patient levels. Health care learned this the hard way. A recent class action lawsuit alleges that Sharp HealthCare used an AI-embedded “ambient clinical documentation” tool to record doctor-patient conversations without obtaining proper consent, and then inaccurately documented that patients had been advised of and consented to the recording when they had not.
The lawsuit isn’t framed as a clinician misconduct case but as a privacy and consent issue, which implies that the problem lies in the organizational deployment and communication of AI use. When health care organizations don’t know how or when AI is being used, the people on the other side, such as patients, cannot be properly informed. Disclosure becomes inconsistent or incomplete, not because of intent, but because leadership itself lacks clarity.
Transparency cannot be treated as patient-facing alone. It has to start at the organizational level. Health care organizations have learned that they need a clear understanding of which systems use AI, how those systems influence documentation or decision-making, and where human judgment remains in control.
This lesson is one of the most important ones health care offers to other industries. Organizations must understand how AI is being used, who is using it, and when. If they do not understand their own AI use, they cannot expect trust from the people they serve.
When governance follows reality
Health care did not arrive at these lessons by design. It arrived at them because AI adoption moved faster than governance, and the consequences left gaps that were impossible to ignore.
That experience matters beyond health care. AI is already embedded in financial systems, legal platforms, education tools, and customer-facing services. In each case, the same pressures will emerge: visibility gaps, accountability questions, and trust challenges.
Health care offers a preview of what happens when governance is delayed — and what becomes necessary to restore control.
What other industries can learn from health care
The health care industry’s experience with AI governance points to a consistent pattern:
- AI adoption spreads faster than policy.
- Embedded systems reduce visibility.
- Accountability must remain human.
- Transparency must start internally before it reaches customers or users.
These lessons are not specific to medicine. They apply anywhere AI is introduced into systems that people rely on.
Health care did not get ahead because it wanted to, but because it had no alternative. Other industries still have the opportunity to learn from those outcomes before similar pressures force the same corrections.
That may be the most valuable lesson health care offers about governing AI.
